Latest News of SVRA
Savara Inc. (SVRA) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 week ago
Savara Inc. has introduced the Savara Early Access Program for aPAP patients, providing molgramostim through an Expanded Access Program in specific regions lacking commercial availability, following l...
Savara, Inc. (SVRA): The Best Multibagger Penny Stock of 2025?
By Yahoo! Finance |
1 month ago
The article discusses the concept of multibagger penny stocks and evaluates Savara, Inc. (NASDAQ:SVRA) in this context. It highlights the potential of Savara's lead therapy, molgramostim, for treating...
Savara Inc.'s (NASDAQ:SVRA) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week
By Yahoo! Finance |
3 months ago
Analyst forecasts and ownership research can help investors evaluate a company's future performance. Institutional investors hold 48% of Savara Inc. shares, leading to a 14% stock price gain last week...
-
Did Savara Inc. (SVRA) Receive a Good Rating from Wall Street Analysts in Q1?
By Yahoo! Finance | 3 months agoA list of top biotech penny stocks includes Savara Inc. (NASDAQ:SVRA), a company focusing on innovative respiratory disease therapies. SVRA's promising Molgramostim product shows potential in treating...